Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study) - Takeaways - MDSpire

Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study)

  • By

  • Kristina A Holten

  • Tomm Bernklev

  • Randi Opheim

  • Bjørn C Olsen

  • Trond Espen Detlie

  • Vibeke Strande

  • Petr Ricanek

  • Raziye Boyar

  • May-Bente Bengtson

  • Tone B Aabrekk

  • Øyvind Asak

  • Svein Oskar Frigstad

  • Vendel A Kristensen

  • Milada Hagen

  • Magne Henriksen

  • Gert Huppertz-Hauss

  • Marte Lie Høivik

  • Lars-Petter Jelsness-Jørgensen

  • November 11, 2024

  • 0 min

Share

  • 1

    Fatigue is prevalent in patients with Crohn's disease and ulcerative colitis, even among those in remission one year post-diagnosis.

  • 2

    Symptomatic remission significantly reduces the odds of substantial fatigue and chronic fatigue in patients with inflammatory bowel disease.

  • 3

    Biochemical remission is associated with reduced odds of substantial fatigue specifically in ulcerative colitis patients.

  • 4

    Chronic fatigue in patients in endoscopic/radiological remission is linked to sleep disturbances and treatment with infliximab.

  • 5

    Stricter definitions of disease remission do not correlate with a decreased likelihood of fatigue among inflammatory bowel disease patients.

Original Source(s)

Related Content